Tall gastrodis tuber combined with antiepileptic drugs repairs abnormal perfusion foci in focal epilepsy
One hundred patients with focal epilepsy were recruited for the present study and their seizures controlled with antiepileptic drugs. The patients then orally received a capsule of tall gastrodis tuber powder, a traditional Chinese drug, and underwent single photon emission computed tomography, long...
Saved in:
Published in | Neural regeneration research Vol. 8; no. 3; pp. 208 - 217 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
India
Medknow Publications and Media Pvt. Ltd
25.01.2013
Medknow Publications & Media Pvt. Ltd Epilepsy Center, Second Hospital, Lanzhou University, Gansu Provincial Center for Prevention and Treatment of Epilepsy, Lanzhou 730030,Gansu Province, China Medknow Publications & Media Pvt Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | One hundred patients with focal epilepsy were recruited for the present study and their seizures controlled with antiepileptic drugs. The patients then orally received a capsule of tall gastrodis tuber powder, a traditional Chinese drug, and underwent single photon emission computed tomography, long-term electroencephalogram, and CT/MRI. Blood drug levels were monitored throughout the study. Before treatment with tall gastrodis tuber, 35 of the 100 cases had abnormal CT/MRI scans; 79 cases had abnormal single photon emission computed tomography images; 86 cases had abnormal electroencephalogram; and a total of 146 abnormal perfusion foci were observed across the 100 subjects. After treatment, the number of patients with normal single photon emission computed tomography images increased by 12; normal electroencephalogram was observed in an additional 27 cases and the number of patients with epileptiform discharge decreased by 29 (34% of 86); the total number of abnormal perfusion foci decreased by 52 (36%) and changes in abnormal loci were visible in 65 patients. These changes indicate that the administration of tall gastrodis tuber in combination with antiepileptic drugs repairs abnormal perfusion foci in patients with focal epilepsy Our results demonstrate that traditional Chinese drugs can repair abnormal perfusion foci and, as such, are a promising new pathway in the treatment of focal epilepsy. |
---|---|
Bibliography: | neural regeneration; traditional Chinese medicine; neuroimaging; brain injury; tall gastrodis tuber;antiepileptic drugs; combination therapy; focal epilepsy; abnormal perfusion focus; single photonemission computed tomography; long-term vigilance-controlled electroencephalogram; region ofinterest; grant-supported paper; photographs-containin~l paper: neuoreaeneration One hundred patients with focal epilepsy were recruited for the present study and their seizures controlled with antiepileptic drugs. The patients then orally received a capsule of tall gastrodis tuber powder, a traditional Chinese drug, and underwent single photon emission computed tomography, long-term electroencephalogram, and CT/MRI. Blood drug levels were monitored throughout the study. Before treatment with tall gastrodis tuber, 35 of the 100 cases had abnormal CT/MRI scans; 79 cases had abnormal single photon emission computed tomography images; 86 cases had abnormal electroencephalogram; and a total of 146 abnormal perfusion foci were observed across the 100 subjects. After treatment, the number of patients with normal single photon emission computed tomography images increased by 12; normal electroencephalogram was observed in an additional 27 cases and the number of patients with epileptiform discharge decreased by 29 (34% of 86); the total number of abnormal perfusion foci decreased by 52 (36%) and changes in abnormal loci were visible in 65 patients. These changes indicate that the administration of tall gastrodis tuber in combination with antiepileptic drugs repairs abnormal perfusion foci in patients with focal epilepsy Our results demonstrate that traditional Chinese drugs can repair abnormal perfusion foci and, as such, are a promising new pathway in the treatment of focal epilepsy. 11-5422/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: Weimin Wang obtained the funding and was in charge of study concept and design, data analysis, manuscript writing and authorization. Zhenyu Fan was responsible for data summary and statistical analysis. Yongqin Zhang, Yuxia Yang, Yaqing Liu, Xiaoli Dang and Wenjun Song performed literature searches. Jiang Ye provided EEG data. Yinping Wu was responsible for the medication of patients. All authors approved the final version of the paper. Author statements: The manuscript is original, has not been submitted to and is not under consideration by another publication, has not been previously published in any language or any form, including electronic, and contains no disclosure of confidential information or authorship/patent application/funding source disputations. Weimin Wang, Professor, Chief physician, Master's supervisor. |
ISSN: | 1673-5374 1876-7958 |
DOI: | 10.3969/j.issn.1673-5374.2013.03.002 |